phenylpropanolamine has been researched along with Bladder Neck Obstruction in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (64.71) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoyano, Y; Kusama, H; Maruyama, I; Maruyama, K; Tatemichi, S; Yamazaki, Y; Yonekubo, S | 1 |
| Wyndaele, JJ | 2 |
| Hwang, EC; Kim, SO; Kwon, D; Oh, KJ; Park, K; Ryu, SB | 1 |
| Andersson, KE; Baroni, E; Benigni, F; D'Ambrosio, D; Gratzke, C; Hedlund, P; Streng, T | 1 |
| Gillespie, JI; Guerard, M; Guilloteau, V; Korstanje, C; Lluel, P; Palea, S | 1 |
| Hatanaka, T; Kaku, S; Ohtake, A; Sato, S; Someya, A; Suzuki, M; Ueshima, K; Ukai, M; Watanabe, M | 1 |
| Brioni, JD; Brune, ME; Coghlan, MJ; Fey, TA; Gopalakrishnan, M; King, LL; Strake, JG; Sullivan, JP | 1 |
| Athanasopoulos, A; Barbalias, G; Fisfis, J; Giannitsas, K; Gyftopoulos, K; Perimenis, P | 1 |
| Chancellor, MB; Kim, HW; Koh, JS; Lee, JY; Lee, SJ; Suh, HJ | 1 |
| Athanasopoulos, AA; Perimenis, PS | 1 |
| Athanasopoulos, A; Perimenis, P | 1 |
| Burnett, AL; Wein, AJ | 1 |
| Abrams, P; De Koning Gans, HJ; Kaplan, S; Millard, R | 1 |
| Schaefer, W | 1 |
| MacDiarmid, S; Rogers, A | 1 |
| Arai, Y; Chancellor, MB; Kaiho, Y; Kwon, DD; Nishiguchi, J; Snyder, PB; Yoshimura, N | 1 |
3 review(s) available for phenylpropanolamine and Bladder Neck Obstruction
| Article | Year |
|---|---|
Efficacy of the combination of an alpha1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Doxazosin; Drug Therapy, Combination; Humans; Male; Phenylpropanolamine; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urodynamics; Urologic Diseases | 2005 |
Benign prostatic hyperplasia in primary care: what you need to know.
Topics: Age Distribution; Aged; Aged, 80 and over; Benzhydryl Compounds; Biopsy, Needle; Cresols; Humans; Immunohistochemistry; Incidence; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prognosis; Prostatic Hyperplasia; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder Neck Obstruction; Urination Disorders | 2006 |
Male overactive bladder: the role of urodynamics and anticholinergics.
Topics: Adult; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Cystoscopy; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Multicenter Studies as Topic; Phenylpropanolamine; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urodynamics | 2007 |
3 trial(s) available for phenylpropanolamine and Bladder Neck Obstruction
| Article | Year |
|---|---|
Efficacy and safety of combined therapy with tamsulosin and tolterodine in female patients with a maximal flow rate less than 12 ml/s.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Retrospective Studies; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Neck Obstruction; Urination | 2011 |
Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urodynamics | 2003 |
Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.
Topics: Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence | 2006 |
11 other study(ies) available for phenylpropanolamine and Bladder Neck Obstruction
| Article | Year |
|---|---|
Effects of ritobegron (KUC-7483), a novel β3-adrenoceptor agonist, on both rat bladder function following partial bladder outlet obstruction and on rat salivary secretion: a comparison with the effects of tolterodine.
Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Animals; Benzhydryl Compounds; Cresols; Female; Male; Muscarinic Antagonists; p-Hydroxyamphetamine; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Saliva; Time Factors; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Neck Obstruction | 2012 |
Editorial comment on: Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Muscarinic Agonists; Organ Size; Phenylpropanolamine; Prostate; Safety; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urologic Diseases | 2009 |
Effects on bladder function of combining elocalcitol and tolterodine in rats with outflow obstruction.
Topics: Animals; Area Under Curve; Benzhydryl Compounds; Calcitriol; Cresols; Drug Therapy, Combination; Female; Infusions, Intravenous; Muscarinic Antagonists; Phenylpropanolamine; Pressure; Rats; Rats, Sprague-Dawley; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics; Vitamins | 2012 |
Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Infusions, Intravenous; Muscarinic Antagonists; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Thiazoles; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urination | 2012 |
Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Benzhydryl Compounds; Cresols; Female; Muscarinic Antagonists; Phenylpropanolamine; Thiazoles; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urination | 2012 |
Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Rats; Rats, Wistar; Thiazoles; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Neck Obstruction | 2013 |
Effects of ATP-sensitive K+ channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstruction.
Topics: Adenosine Triphosphate; Animals; Benzhydryl Compounds; Benzoxazines; Cresols; Cromakalim; Cyclic N-Oxides; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ion Channel Gating; Muscarinic Antagonists; Muscle Contraction; Oxazines; Parasympatholytics; Phenylpropanolamine; Potassium Channels; Sus scrofa; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics | 2003 |
Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Doxazosin; Humans; Male; Middle Aged; Phenylpropanolamine; Prospective Studies; Prostatic Hyperplasia; Tartrates; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urodynamics | 2004 |
Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
Topics: Benzhydryl Compounds; Cresols; Doxazosin; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence | 2005 |
Re: safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.
Topics: Benzhydryl Compounds; Cresols; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive | 2006 |
The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
Topics: Animals; Benzhydryl Compounds; Cresols; Female; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urodynamics | 2008 |